Log In
BCIQ
Print this Print this
 

doxylamine/pyridoxine (Diclectin, Diclegis)

  Manage Alerts
Collapse Summary General Information
Company Duchesnay Inc.
DescriptionDelayed-release tablet containing 10 mg doxylamine and 10 mg pyridoxine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationEmesis
Indication DetailsManage pregnancy-induced nausea and vomiting
Regulatory Designation
PartnerAlliance Pharma plc;
Tzamal Medical Group Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/21/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today